NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $777,950 | -0.4% | 10,606 | +3.2% | 0.02% | -6.2% |
Q3 2022 | $781,000 | +19.4% | 10,273 | +9.2% | 0.02% | +33.3% |
Q2 2022 | $654,000 | -20.3% | 9,405 | -5.1% | 0.01% | -7.7% |
Q1 2022 | $821,000 | -2.0% | 9,912 | -11.2% | 0.01% | +8.3% |
Q4 2021 | $838,000 | -67.4% | 11,160 | -3.6% | 0.01% | -70.7% |
Q3 2021 | $2,567,000 | 0.0% | 11,574 | 0.0% | 0.04% | +20.6% |
Q2 2021 | $2,567,000 | +85.1% | 11,574 | +10.3% | 0.03% | +61.9% |
Q1 2021 | $1,387,000 | -61.6% | 10,490 | -49.8% | 0.02% | -62.5% |
Q4 2020 | $3,615,000 | +203.3% | 20,892 | +95.1% | 0.06% | +180.0% |
Q3 2020 | $1,192,000 | +23740.0% | 10,706 | +19725.9% | 0.02% | – |
Q4 2019 | $5,000 | – | 54 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |